RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.000
-0.010 (-0.99%)
At close: Mar 20, 2026, 4:00 PM EDT
1.000
0.00 (0.00%)
After-hours: Mar 20, 2026, 4:10 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $36.65 million as of March 20, 2026. Its market cap has increased by 8.46% in one year.
Market Cap
36.65M
Enterprise Value
27.21M
1-Year Change
8.46%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $36.65M, a decrease of -46.61%. That is a compound annual growth rate of -12.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 37.02M | 20.22% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 39.94M |
| Palatin Technologies | 39.45M |
| Werewolf Therapeutics | 39.32M |
| CervoMed | 39.16M |
| LeonaBio | 39.16M |
| Sensei Biotherapeutics | 38.54M |
| Veru Inc. | 36.76M |
| Celularity | 36.62M |